The surgical management of severe obesity

Mount Sinai Journal of Medicine

Volumn 71, Issue 1, 2004, Pages 63-71

  Herron, Daniel M ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Adjustable gastric band; Bariatric surgery; Bilionpancreatic diversion; Gastric bypass; Morbid obesity; Obesity; Severe obesity

Indexed keywords

ANOREXIGENIC AGENT; DOPAMINE; FENFLURAMINE; NORADRENALIN; PHENTERMINE; SEROTONIN; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; COST OF ILLNESS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC; GASTRIC BANDING; HEALTH CARE COST; HUMAN; LAPAROSCOPIC SURGERY; MORBIDITY; OBESITY; PATIENT CARE; PATIENT SELECTION; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREVALENCE; STOMACH BYPASS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNITED STATES; VALVULAR HEART DISEASE; WEIGHT REDUCTION;

BILIOPANCREATIC DIVERSION; BODY MASS INDEX; GASTRIC BYPASS; GASTROPLASTY; HUMANS; LAPAROSCOPY; OBESITY, MORBID; TREATMENT OUTCOME;

EID: 0942266263     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999; 282:1519-1522.
2. Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341:1097-1105.
3. Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in the United States. JAMA 1999; 282:1530-1538.
4. Quesenberry CP, Jr., Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Int Med 1998; 158:466-472.
5. Thompson D. Health care costs. Innovus Research. Accessed 6/4/2001. http://cardiology.medscape.com/reuters/prof/2001/06/06.01/ 20010531econ001.html
6. National Institutes of Health (NIH): National Heart, Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. www.nhlbi.hih.gov/guidelines/obesity/oblns.pdf on p. 16.
7. Pouliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73:460-468.
8. WHO Update: controlling the global obesity epidemic. http://www.who.int/nut/obs.htm. Accessed 2/27/2002.
9. National Health Center for Health Statistics: prevalence of overweight and obesity among adults, United States, 1999. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/obese/obse99.htm. Accessed 2/27/2002.
10. Wadden TA. Treatment of obesity by moderate and severe caloric restriction: results of clinical research trials. Ann Int Med 1993; 119:688-693.
11. Serdula MK, Mokdad AH, Williamson DF, et al. Prevalence of attempting weight loss and strategies for controlling weight. JAMA 1999; 282:1353-1358.
12. National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA 1996; 276:1907-1915.
13. Weintraub M. Long-term weight control study: conclusions. Clin Pharmacol Ther 1992; 51:642-646.
14. Fanghanel G, Cortinas L, Sanchez-Reyes L, Berber A. A clinical trial of the use of sibutramine for the treatment of patients suffering essential obesity. Int J Obes Relat Metab Disord 2000; 24:144-150.
15. McMahon F, Fujioka K, Singh B, et al. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a one-year double-blind placebo-controlled multicenter trial. Arch Int Med 2000; 160:2185-2191.
16. Klein S. Medical management of obesity. Surg Clin North Am 2001; 81:1025-1028.
17. Gastrointestinal surgery for severe obesity. Consensus Statement: NIH Consensus Development Conference, March 25-26, 1991; 9(1):1-20; http://consensus.nih.gov/cons/084/084_intro.htm
18. Mason EE, Ito CC. Gastric bypass in obesity. Surg Clin North Am 1967; 47:1345-1354.
19. Brolin RE, Kenler HA, Gorman JH, et al. Long-limb gastric bypass in the super-obese: a prospective randomized study. Ann Surg 1992; 215:387-395.
20. MacLean LD, Rhode BM, Nohr CW. Late outcome of isolated gastric bypass. Ann Surg 2000; 231:524-528.
21. Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Rouxen-Y technique and results in 75 patients with 3-30 months followup. Obes Surg 1996; 6:500-504.
22. Higa KD, Boone KB, Ho T, Davies OG. Laparoscopic Roux-en-Y gastric bypass for morbid obesity: technique and preliminary results of our first 400 patients. Arch Surg 2000; 135:1029-1034.
23. Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000; 232:515-529.
24. Nguyen NT, Lee SL, Goldman C, et al. Comparison of pulmonary function and postoperative pain after laparoscopic versus open gastric bypass: a randomized trial. J Am Coll Surg 2001; 192:469-477.
25. Wudel LJ, Jr, Wright JK, Debelak JP, et al. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res 2002; 102(1):50-56.
26. Kremen AJ, Linner JH, Nelson CH. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg 1954; 140:439-448.
27. Griffen WO, Bivins BA, Bell RM. The decline and fall of the jejunoileal bypass. Surg Gynecol Obstet 1983; 157:301-308.
28. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg 1998; 22:936-946.
29. Marceau P, Hould F-S, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22:947-954.
30. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg 1998; 8:267-282.
31. Ren CJ, Patterson E, Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg 2000; 10:514-523.
32. Balsiger BM, Poggio JL, Mai J, et al. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg 2000; 4:598-605.
33. MacLean LD, Rhode BM, Sampalis J, Forse RA. Results of the surgical treatment of obesity. Am J Surg 1993; 165:155-162.
34. Chevallier JM, Zinzindohoue F, Elian N, et al. Adjustable gastric banding in a public university hospital: prospective analysis of 400 patients. Obes Surg 2002; 12:93-99.
35. Fielding GA, Rhodes M, Nathanson LK. Laparoscopic gastric banding for morbid obesity: surgical outcomes in 335 cases. Surg Endosc 1999; 13:550-554.
36. DeMaria EJ, Sugerman HJ, Meador JG, et al. High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. Ann Surg 2001; 233(6):809-818.
37. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222(3):339-350.
38. MacDonald K, Schauer P, Brolin R, et al. Bariatric surgery - a review. General Surgery News 2002; June: 19-26.
39. MacDonald KG, Jr, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997; 1:213-220.
40. Schueller M, Weider D. Bariatric surgery for treatment of sleep apnea syndrome in 15 morbidly obese patients: long-term results. Otolaryngol Head Neck Surg 2001; 125(4):299-302.
41. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994; 79:1147-1156.
42. Intellihealth.com website. http://www.intellihealth.com/IH/ihtIH/WSIHW000/333/7228/344670.html. Accessed 3/2/02.
43. Committee on Emerging Surgical Technology and Education, American College of Surgeons. Recommendations for facilities performing bariatric surgery. Bull Am Coll Surg 2000; 85 (9):20-23.